Question: Would you rather buy the beer or the stock?
AdvisorShares Psychedelics ETF, which is adding Mindset Pharma and lists Cybin as a top holding, looks like a good trip.
I'm looking for a continuation of strong pockets of speculative action.
To help readers navigate this mushrooming opportunity, I've put together a list of the top corporate leaders in the field.
GRVI caters to multiple market segments like Beauty, Pet Care, Botanical Health & Wellness, Rare Cannabinoids, and even trade shows.
ETF MSOS is seen as an opportunity to get exposure to stocks that are not yet U.S. listed.
That's why I own it and added to it Monday.
This kind of market action eventually leads to attractive stock-picking opportunities.
As feds remain a drag on industry, biotech has high hopes for national reform. Here, we talk with Oludare Odumosu about what could be ahead.
Urban-gro is a small company under the radar with substantial growth.
I'm willing to take a small shot on a September call spread and ride through earnings.
Small-cap earnings season begins, but the dog days of summer make for dull trading action.
This is still a tricky trading market with many small-caps languishing due to a lack of interest.
As legislation that would let pot stocks list on Nasdaq fails to take root, I'm cultivating other opportunities.
I'm becoming more confident that small-caps have bottomed heading into earnings.
Several names I like are slow fading due to disinterest in small-caps.
One group acting better is the MSO (multi-state operator) pot names.
Just because the volume is lighter, it doesn't make the gains any less real.
Viridian Capital believes Michigan could be the third biggest state for cannabis sales behind California and Colorado.
Traders could maintain longs but raise stop protection.
With a portfolio of 10 names that fit this category, I only need to be correct on one to be profitable. If I hit on more than one, I'm crushing it. And if I hit on three...
The cannabis sector is finally turning back up after a sharp correction that started in early February.
Leading advisors offer their favorite ideas for investors looking for exposure to the growing marijuana market.
The main names that I'm focused on are leveraged to growth in the U.S.
The cannabis biotech company explains why the acquisition of MagicMed makes sense, additional capital raises and the Psybrary.
The charts of the retailer of hydroponic products have improved over the last few months.
I see an opportunity in Hydrofarm Holdings.
Let's check out the charts of the hydroponics supplier.
It's not the multistate operators, but the single-state ones that are where the cool kids are hanging out.
However, a key chart of the producer of beer, wine and spirits indicates the strength of the uptrend could be weakening.